EQT-Backed Biotech Firm Evommune Raises $150 Million in IPO
PositiveFinancial Markets

EQT-Backed Biotech Firm Evommune Raises $150 Million in IPO
Evommune Inc., a biotech firm focused on chronic inflammatory diseases, successfully raised $150 million in its initial public offering. This achievement is significant as it highlights the resilience of the biotech sector, allowing companies to go public even amid challenges like the US government shutdown. Such funding can accelerate research and development, potentially leading to breakthroughs in treating chronic conditions.
— via World Pulse Now AI Editorial System







